Previous 10 | Next 10 |
PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has completed its previously announced divestiture of its Extremity Orthopedics business to Smith+Nephew (LSE:SN, N...
PRINCETON, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Peter Arduini, president and chief executive officer will present virtually at the 39 th Annual J.P. Morgan ...
Integra LifeSciences (IART) has agreed to acquire ACell, a regenerative medicine company with a product portfolio based on porcine urinary bladder matrix platform technology, MatriStem UBM. The acquisition will help the expansion of Integra’s Orthopedics and Tissue Technologies se...
PRINCETON, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a definitive agreement to acquire ACell, Inc. (“ACell”) for an upfront cash payment o...
Integra LifeSciences is in the late stages of a transition period, rounded off by the recent divestiture of the orthopaedics segment, to be closed next year. The company has had a strong sequential quarter, which may carry through to Q4 should the pandemic begin to settle over a resur...
Smith & Nephew has failed to make its recovery to pre-pandemic levels, although key segments are likely in a deferral rather than a long-term loss. Lack of visibility and guidance from management highlights the risks investors must factor in, and reflects the pricing activity we'v...
Image source: The Motley Fool. Integra Lifesciences Holdings Corp (NASDAQ: IART) Q3 2020 Earnings Call Oct 28, 2020 , 8:30 a.m. ET Operator Continue reading For further details see: Integra Lifesciences Holdings Corp (IART) Q3 2020 Earnin...
Integra LifeSciences Holdings Corporation (IART) Q3 2020 Earnings Conference Call October 28, 2020 08:30 AM ET Company Participants Mike Beaulieu - Director, Investor Relations Carrie Anderson - Chief Financial Officer Glenn Coleman - Chief Operating Officer Peter Arduini - President & Ch...
Integra LifeSciences Holdings (IART): Q3 Non-GAAP EPS of $0.80 beats by $0.26; GAAP EPS of $0.38 beats by $0.22.Revenue of $370.2M (-2.3% Y/Y) beats by $10.88M.Press Release For further details see: Integra LifeSciences Holdings EPS beats by $0.26, beats on revenue
PRINCETON, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2020. Third Quarter 2020 Financial Summary ...
News, Short Squeeze, Breakout and More Instantly...
Integra LifeSciences Holdings Corporation Company Name:
IART Stock Symbol:
NASDAQ Market:
2024-07-30 13:15:02 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for IART on July 30, 2024 11:36AM ET. The previous analyst recommendation was Market Outperform. IART was trading at $24.945 at issue of the analyst recommendation. The overall analyst ...
2024-07-30 10:00:08 ET Richard Newitter from Truist Financial issued a price target of $26.00 for IART on 2024-07-30 08:59:00. The adjusted price target was set to $26.00. At the time of the announcement, IART was trading at $24.59. The overall price target consensus is ...
2024-07-30 06:30:09 ET Citigroup analyst issues SELL recommendation for IART on July 30, 2024 03:24AM ET. The previous analyst recommendation was Neutral. IART was trading at $25.42 at issue of the analyst recommendation. The overall analyst consensus : SELL. Current...